Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
So the mould of British politics has been broken, and we now have a government with probably a broader range …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader

